The present invention relates to a pharmaceutical composition for inhalation. The invention is further directed to a method for manufacturing said pharmaceutical composition and the use of it in the treatment of asthma, allergies, infectious diseases and diseases of the cardiovascular system. This is achieved by a pharmaceutical composition for inhalation containing at least two active ingredients and at least two pharmaceutically acceptable excipients, wherein the active ingredients are adhered to said excipients, and wherein each active ingredient is adhered to a different excipient.
